InMed Pharmaceuticals is pleased to welcome the BayMedica team following its acquisition in October 2021.
Meet Shane Johnson, our Senior Vice President and General Manager. Shane talks about how his interest in cannabinoid biosynthesis began when he saw the challenges of cannabis cultivation through a company he founded. With Charles Marlowe and Philip Barr, he founded BayMedica with a goal to leverage biosynthesis to manufacture cannabinoids and overcome the challenges of cannabis cultivation.
Shane holds a B.A. in Studio Art and a B.S. in Neuroscience (with honors) from Brown University, an M.D. from the Stanford University School of Medicine, and is a Fulbright Scholar.